Emotional Distress May Confer Worse Immunotherapy Outcomes in NSCLC
Prior data from the STRESS-LUNG-1 trial introduced emotional distress as a “psycho-biomarker” for immunotherapy efficacy in non–small cell lung cancer.
Previous Post
AI Model Using EHR Data Predicts 5-Year Survival in Colorectal Cancer
Next Post
Related Melioidosis Cases with Unknown Exposure Source, Georgia, USA, 1983–2024
📢
Advertisement
300x250 Banner
Recent Content
COPD Biologics: Early Treatment Insights
Pulmonology • 2 hours ago
Antihypertensive Medication Guidelines
Cardiology • 4 hours ago
Juvenile Arthritis Care Transition
Rheumatology • 6 hours ago